glp-1 review article Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Dual GIP/GLP-1 receptor agonists: New

Ask us about NAD+ therapy for energy, focus, and recovery, available by IV drip or injection

This compensation does not affect the price you pay and helps support continued research and content publication

The therapeutic agent liraglutide alleviates ferroptosis by attenuating lipid peroxidation, thereby mitigating its detrimental effects on hippocampal neurons and synaptic plasticity, and ultimately delaying the onset and progression of DACD (Figure 3)

Common causes include: Pernicious anaemia Malabsorption disorders (e.g., coeliac disease, Crohns) Chronic alcohol abuse Long-term use of antacids or metformin Vegan or vegetarian diet without supplementation 3

Minimize chemical treatments

From screening to treatment: the new landscape of diabetic kidney disease